# Xylem Inc.: financial statements, quarterly XYL · NYSE · CIK 1524472 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/xyl.md) · [Financials](/companies/xyl/financials.md) · [Filings](/companies/xyl/filings.md) · [Insiders](/companies/xyl/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/xyl/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [2,118 d](/filings/0001524472-26-000012.md) | [2,033](/filings/0001524472-25-000022.md) | [2,169](/filings/0001524472-25-000037.md) | [2,104](/filings/0001524472-25-000046.md) | [2,256 d](/filings/0001524472-26-000012.md) | [2,069](/filings/0001524472-26-000068.md) | [2,301](/filings/0001524472-26-000110.md) | [2,268](/filings/0001524472-26-000148.md) | [2,397 d](/filings/0001524472-26-000012.md) | [2,125](/filings/0001524472-26-000068.md) | [2,336](/filings/0001524472-26-000110.md) | [2,201](/filings/0001524472-26-000148.md) | | Cost of revenue | $m | [1,362 d](/filings/0001524472-26-000012.md) | [1,281](/filings/0001524472-25-000022.md) | [1,350](/filings/0001524472-25-000037.md) | [1,320](/filings/0001524472-25-000046.md) | [1,399 d](/filings/0001524472-26-000012.md) | [1,301](/filings/0001524472-26-000068.md) | [1,409](/filings/0001524472-26-000110.md) | [1,385](/filings/0001524472-26-000148.md) | [1,465 d](/filings/0001524472-26-000012.md) | [1,322](/filings/0001524472-26-000068.md) | [1,373](/filings/0001524472-26-000110.md) | [1,294](/filings/0001524472-26-000148.md) | | Gross profit | $m | [756 d](/filings/0001524472-26-000012.md) | [752](/filings/0001524472-25-000022.md) | [819](/filings/0001524472-25-000037.md) | [784](/filings/0001524472-25-000046.md) | [857 d](/filings/0001524472-26-000012.md) | [768](/filings/0001524472-26-000068.md) | [892](/filings/0001524472-26-000110.md) | [883](/filings/0001524472-26-000148.md) | [932 d](/filings/0001524472-26-000012.md) | [803](/filings/0001524472-26-000068.md) | [963](/filings/0001524472-26-000110.md) | [907](/filings/0001524472-26-000148.md) | | Research and development | $m | [60.0 d](/filings/0001524472-26-000012.md) | [59.0](/filings/0001524472-25-000022.md) | [58.0](/filings/0001524472-25-000037.md) | [55.0](/filings/0001524472-25-000046.md) | [58.0 d](/filings/0001524472-26-000012.md) | [56.0](/filings/0001524472-26-000068.md) | [58.0](/filings/0001524472-26-000110.md) | [52.0](/filings/0001524472-26-000148.md) | [60.0 d](/filings/0001524472-26-000012.md) | [56.0](/filings/0001524472-26-000068.md) | [59.0](/filings/0001524472-26-000110.md) | [56.0](/filings/0001524472-26-000148.md) | | Selling, general and administrative | $m | [466 d](/filings/0001524472-26-000012.md) | [474](/filings/0001524472-25-000022.md) | [485](/filings/0001524472-25-000037.md) | [445](/filings/0001524472-25-000046.md) | [507 d](/filings/0001524472-26-000012.md) | [460](/filings/0001524472-26-000068.md) | [503](/filings/0001524472-26-000110.md) | [474](/filings/0001524472-26-000148.md) | [486 d](/filings/0001524472-26-000012.md) | [472](/filings/0001524472-26-000068.md) | [503](/filings/0001524472-26-000110.md) | [458](/filings/0001524472-26-000148.md) | | Operating income | $m | [211 d](/filings/0001524472-26-000012.md) | [209](/filings/0001524472-25-000022.md) | [253](/filings/0001524472-25-000037.md) | [280](/filings/0001524472-25-000046.md) | [267 d](/filings/0001524472-26-000012.md) | [231](/filings/0001524472-26-000068.md) | [305](/filings/0001524472-26-000110.md) | [334](/filings/0001524472-26-000148.md) | [353 d](/filings/0001524472-26-000012.md) | [244](/filings/0001524472-26-000068.md) | [390](/filings/0001524472-26-000110.md) | [385](/filings/0001524472-26-000148.md) | | Interest expense | $m | [14.0 d](/filings/0001524472-24-000006.md) | [14.0](/filings/0001524472-24-000015.md) | [11.0](/filings/0001524472-24-000033.md) | [10.0](/filings/0001524472-24-000045.md) | [9.0 d](/filings/0001524472-26-000012.md) | [8.0](/filings/0001524472-26-000068.md) | [9.0](/filings/0001524472-26-000110.md) | [6.0](/filings/0001524472-26-000148.md) | [6.0 d](/filings/0001524472-26-000012.md) | [4.0](/filings/0001524472-26-000068.md) | [7.0](/filings/0001524472-26-000110.md) | [21.0](/filings/0001524472-26-000148.md) | | Income tax | $m | [(56.0) d](/filings/0001524472-26-000012.md) | [43.0](/filings/0001524472-25-000022.md) | [53.0](/filings/0001524472-25-000037.md) | [52.0](/filings/0001524472-25-000046.md) | [49.0 d](/filings/0001524472-26-000012.md) | [50.0](/filings/0001524472-26-000068.md) | [75.0](/filings/0001524472-26-000110.md) | [71.0](/filings/0001524472-26-000148.md) | [35.0 d](/filings/0001524472-26-000012.md) | [55.0](/filings/0001524472-26-000068.md) | [103](/filings/0001524472-26-000110.md) | [77.0](/filings/0001524472-26-000148.md) | | Net income | $m | [266 d](/filings/0001524472-26-000012.md) | [153](/filings/0001524472-25-000046.md) | [194](/filings/0001524472-25-000046.md) | [217](/filings/0001524472-25-000046.md) | [326 d](/filings/0001524472-26-000012.md) | [169](/filings/0001524472-26-000148.md) | [226](/filings/0001524472-26-000148.md) | [227](/filings/0001524472-26-000148.md) | [335 d](/filings/0001524472-26-000012.md) | [193](/filings/0001524472-26-000148.md) | [263](/filings/0001524472-26-000148.md) | [291](/filings/0001524472-26-000148.md) | | Diluted EPS | $ per share | not reported | [0.63](/filings/0001524472-25-000022.md) | [0.80](/filings/0001524472-25-000037.md) | [0.89](/filings/0001524472-25-000046.md) | not reported | [0.69](/filings/0001524472-26-000068.md) | [0.93](/filings/0001524472-26-000110.md) | [0.93](/filings/0001524472-26-000148.md) | not reported | [0.79](/filings/0001524472-26-000068.md) | [1.11](/filings/0001524472-26-000110.md) | [1.25](/filings/0001524472-26-000148.md) | | Basic EPS | $ per share | not reported | [0.63](/filings/0001524472-25-000022.md) | [0.80](/filings/0001524472-25-000037.md) | [0.89](/filings/0001524472-25-000046.md) | not reported | [0.69](/filings/0001524472-26-000068.md) | [0.93](/filings/0001524472-26-000110.md) | [0.93](/filings/0001524472-26-000148.md) | not reported | [0.79](/filings/0001524472-26-000068.md) | [1.11](/filings/0001524472-26-000110.md) | [1.25](/filings/0001524472-26-000148.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [1.0](/filings/0001524472-25-000013.md) | [0.9](/filings/0001524472-24-000015.md) | [0.8](/filings/0001524472-24-000033.md) | [1.0](/filings/0001524472-24-000045.md) | [1.1](/filings/0001524472-26-000012.md) | [1.1](/filings/0001524472-25-000022.md) | [1.2](/filings/0001524472-25-000037.md) | [1.2](/filings/0001524472-25-000046.md) | [1.5](/filings/0001524472-26-000148.md) | [0.8](/filings/0001524472-26-000068.md) | [1.3](/filings/0001524472-26-000110.md) | [0.7](/filings/0001524472-26-000148.md) | | Current assets | $bn | [3.9](/filings/0001524472-25-000013.md) | [3.9](/filings/0001524472-24-000015.md) | [3.8](/filings/0001524472-24-000033.md) | [4.0](/filings/0001524472-24-000045.md) | [4.1](/filings/0001524472-26-000012.md) | [4.1](/filings/0001524472-25-000022.md) | [4.4](/filings/0001524472-25-000037.md) | [4.4](/filings/0001524472-25-000046.md) | [4.6](/filings/0001524472-26-000148.md) | [4.0](/filings/0001524472-26-000068.md) | [4.4](/filings/0001524472-26-000110.md) | [4.0](/filings/0001524472-26-000148.md) | | Total assets | $bn | [16.1](/filings/0001524472-25-000013.md) | [15.9](/filings/0001524472-24-000015.md) | [15.8](/filings/0001524472-24-000033.md) | [16.0](/filings/0001524472-24-000045.md) | [16.5](/filings/0001524472-26-000012.md) | [16.6](/filings/0001524472-25-000022.md) | [17.2](/filings/0001524472-25-000037.md) | [17.3](/filings/0001524472-25-000046.md) | [17.6](/filings/0001524472-26-000148.md) | [17.0](/filings/0001524472-26-000068.md) | [17.3](/filings/0001524472-26-000110.md) | [17.3](/filings/0001524472-26-000148.md) | | Current liabilities | $bn | [2.2](/filings/0001524472-25-000013.md) | [2.3](/filings/0001524472-24-000015.md) | [2.0](/filings/0001524472-24-000033.md) | [2.1](/filings/0001524472-24-000045.md) | [2.3](/filings/0001524472-26-000012.md) | [2.2](/filings/0001524472-25-000022.md) | [2.3](/filings/0001524472-25-000037.md) | [2.3](/filings/0001524472-25-000046.md) | [2.9](/filings/0001524472-26-000148.md) | [2.8](/filings/0001524472-26-000068.md) | [2.7](/filings/0001524472-26-000110.md) | [2.8](/filings/0001524472-26-000148.md) | | Total liabilities | $bn | [5.9](/filings/0001524472-25-000013.md) | [5.7](/filings/0001524472-24-000015.md) | [5.4](/filings/0001524472-24-000033.md) | [5.4](/filings/0001524472-24-000045.md) | [5.6](/filings/0001524472-26-000012.md) | [5.5](/filings/0001524472-25-000022.md) | [5.9](/filings/0001524472-25-000037.md) | [5.9](/filings/0001524472-25-000046.md) | [5.9](/filings/0001524472-26-000148.md) | [5.7](/filings/0001524472-26-000068.md) | [6.7](/filings/0001524472-26-000110.md) | [6.8](/filings/0001524472-26-000148.md) | | Long-term debt | $bn | [2.3](/filings/0001524472-25-000013.md) | [2.0](/filings/0001524472-24-000015.md) | [2.0](/filings/0001524472-24-000033.md) | [2.0](/filings/0001524472-24-000045.md) | [2.0](/filings/0001524472-26-000012.md) | [2.0](/filings/0001524472-25-000022.md) | [1.9](/filings/0001524472-25-000037.md) | [1.9](/filings/0001524472-25-000046.md) | [1.4](/filings/0001524472-26-000148.md) | [1.4](/filings/0001524472-26-000068.md) | [2.4](/filings/0001524472-26-000110.md) | [2.4](/filings/0001524472-26-000148.md) | | Current portion of debt | $bn | [0.0](/filings/0001524472-24-000045.md) | [0.3](/filings/0001524472-24-000015.md) | [0.0](/filings/0001524472-24-000033.md) | [0.0](/filings/0001524472-24-000045.md) | [0.0](/filings/0001524472-25-000046.md) | [0.0](/filings/0001524472-25-000022.md) | [0.1](/filings/0001524472-25-000037.md) | [0.0](/filings/0001524472-25-000046.md) | [0.5](/filings/0001524472-26-000110.md) | [0.5](/filings/0001524472-26-000068.md) | [0.5](/filings/0001524472-26-000110.md) | not reported | | Short-term borrowings | $bn | [0.0](/filings/0001524472-25-000013.md) | not reported | not reported | not reported | [0.0](/filings/0001524472-26-000012.md) | not reported | not reported | not reported | [0.5](/filings/0001524472-26-000148.md) | not reported | not reported | [0.5](/filings/0001524472-26-000148.md) | | Shareholders' equity | $bn | [10.2](/filings/0001524472-25-000013.md) | [10.2](/filings/0001524472-24-000015.md) | [10.3](/filings/0001524472-24-000033.md) | [10.6](/filings/0001524472-24-000045.md) | [10.6](/filings/0001524472-26-000012.md) | [10.8](/filings/0001524472-25-000022.md) | [11.1](/filings/0001524472-25-000037.md) | [11.2](/filings/0001524472-25-000046.md) | [11.5](/filings/0001524472-26-000148.md) | [11.0](/filings/0001524472-26-000068.md) | [10.4](/filings/0001524472-26-000110.md) | [10.3](/filings/0001524472-26-000148.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:DebtCurrent - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [455 d](/filings/0001524472-26-000012.md) | [89.0](/filings/0001524472-25-000022.md) | [288 d](/filings/0001524472-25-000037.md) | [311 d](/filings/0001524472-25-000046.md) | [575 d](/filings/0001524472-26-000012.md) | [33.0](/filings/0001524472-26-000068.md) | [305 d](/filings/0001524472-26-000110.md) | [360 d](/filings/0001524472-26-000148.md) | [543 d](/filings/0001524472-26-000012.md) | [108](/filings/0001524472-26-000068.md) | [290 d](/filings/0001524472-26-000110.md) | [331 d](/filings/0001524472-26-000148.md) | | Capital expenditure | $m | [94.0 d](/filings/0001524472-26-000012.md) | [74.0](/filings/0001524472-25-000022.md) | [73.0](/filings/0001524472-24-000033.md) | [74.0](/filings/0001524472-24-000045.md) | [100 d](/filings/0001524472-26-000012.md) | [71.0](/filings/0001524472-26-000068.md) | [98.0 d](/filings/0001524472-26-000110.md) | [79.0 d](/filings/0001524472-26-000148.md) | [83.0 d](/filings/0001524472-26-000012.md) | [90.0](/filings/0001524472-26-000068.md) | [89.0 d](/filings/0001524472-26-000110.md) | [89.0 d](/filings/0001524472-26-000148.md) | | Dividends paid | $m | [80.0 d](/filings/0001524472-26-000012.md) | [88.0](/filings/0001524472-25-000022.md) | [87.0 d](/filings/0001524472-25-000037.md) | [88.0 d](/filings/0001524472-25-000046.md) | [87.0 d](/filings/0001524472-26-000012.md) | [98.0](/filings/0001524472-26-000068.md) | [98.0 d](/filings/0001524472-26-000110.md) | [97.0 d](/filings/0001524472-26-000148.md) | [98.0 d](/filings/0001524472-26-000012.md) | [106](/filings/0001524472-26-000068.md) | [101 d](/filings/0001524472-26-000110.md) | [100 d](/filings/0001524472-26-000148.md) | | Share repurchases | $m | [15.0 d](/filings/0001524472-26-000012.md) | [15.0](/filings/0001524472-25-000022.md) | [3.0 d](/filings/0001524472-25-000037.md) | [1.0 d](/filings/0001524472-25-000046.md) | [1.0 d](/filings/0001524472-26-000012.md) | [13.0](/filings/0001524472-26-000068.md) | [0.0 d](/filings/0001524472-26-000110.md) | [1.0 d](/filings/0001524472-26-000148.md) | [1.0 d](/filings/0001524472-26-000012.md) | [563](/filings/0001524472-26-000068.md) | [680 d](/filings/0001524472-26-000110.md) | [337 d](/filings/0001524472-26-000148.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [181](/filings/0001524472-24-000015.md) | [207](/filings/0001524472-24-000033.md) | [242](/filings/0001524472-24-000045.md) | [243](/filings/0001524472-25-000022.md) | [244](/filings/0001524472-25-000037.md) | [244](/filings/0001524472-25-000046.md) | [244](/filings/0001524472-26-000068.md) | [244](/filings/0001524472-26-000110.md) | [244](/filings/0001524472-26-000148.md) | [243](/filings/0001524472-26-000068.md) | [237](/filings/0001524472-26-000110.md) | [233](/filings/0001524472-26-000148.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 229,334,592 at 2026-10-23, from the cover of the [10-Q filed 2026-10-27](/filings/0001524472-26-000148.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:51 ET. No prices; not investment advice.